FDA — authorised 2 October 2017
- Application: NDA208772
- Marketing authorisation holder: TAKEDA PHARMS USA
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Alunbrig in United States
FDA authorised Alunbrig on 2 October 2017
Marketing authorisation
Alunbrig in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Alunbrig approved in United States?
Yes. FDA authorised it on 2 October 2017.
Who is the marketing authorisation holder for Alunbrig in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.